A carregar...
RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations
Introduction: Novel immune globulin (IG) products (RI-002, RI-001) have been designed to provide protection against respiratory syncytial virus (RSV) mediated respiratory illness while at the same time meeting the manufacturing requirements established by FDA for antibody supplementation in immunoco...
Na minha lista:
| Publicado no: | Expert Rev Clin Immunol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7103707/ https://ncbi.nlm.nih.gov/pubmed/29035131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1744666X.2017.1389647 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|